Discovery Could Lead To Testing That Displaces Colonoscopies
University of Missouri researchers believe that predicting colon cancer in mice could eventually benefit humans.
Read MorePosted by Clinical Lab Products | Feb 20, 2011 | Cancer, Miscellaneous |
University of Missouri researchers believe that predicting colon cancer in mice could eventually benefit humans.
Read MorePosted by Clinical Lab Products | Jan 13, 2011 | Miscellaneous |
AlereG-BiosciencesFluoresentric IncViroStat IncMolecular Detection IncCerilliant CorpOrtho Clinical DiagnosticsPerkinElmer Life Sciences
Read MorePosted by Clinical Lab Products | Jan 3, 2011 | Company News |
The company has closed on $6.0 million of financing from Third Security LLC to fund the cash portion of Transgenomic’s acquisition of Clinical Data’s diagnostic business.
Read MorePosted by Clinical Lab Products | Dec 23, 2010 | Cancer, Melanoma, Miscellaneous |
The vast majority of parents who tested positive for a genetic mutation that increases the risk of melanoma support genetic testing of their children or grandchildren.
Read MorePosted by Clinical Lab Products | Dec 22, 2010 | Miscellaneous |
Exagen Diagnostics Inc has been awarded $400,000 in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program.
Read More